Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.

Sathler-Avelar, R; Vitelli-Avelar, D M; Massara, R L; Borges, J D; Lana, M; Teixeira-Carvalho, A; Dias, J C P; Elói-Santos, S M; Martins-Filho, O A

Sathler-Avelar, R; Vitelli-Avelar, D M; Massara, R L; Borges, J D; Lana, M; Teixeira-Carvalho, A; Dias, J C P; Elói-Santos, S M; Martins-Filho, O A.

Affiliation

Sathler-Avelar R; Laboratório de Doença de Chagas, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil. avelar@cpqrr.fiocruz.br

Scand J Immunol ; 64(5): 554-63, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17032249

Subject(s)

Chagas Disease/immunology; Cytokines/blood; Gene Expression; Immunity, Innate; Nitroimidazoles/therapeutic use; Trypanosoma cruzi/immunology; Adolescent; Animals; Case-Control Studies; Chagas Disease/therapy; Child; Female; Humans; Longitudinal Studies; Male

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Trypanosoma cruzi / Gene Expression / Cytokines / Chagas Disease / Immunity, Innate / Nitroimidazoles Type of study: Observational_studies Limits: Adolescent / Animals / Child / Female / Humans / Male Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links